SICK is a wholesaler in Asse. Public Limited, started on 29 June 1987, 1 establishment.

What is the address of SICK?

The registered office of SICK is located at Doornveld 10, 1731 Asse.

Is SICK still active?

Yes. According to the CBE (29 October 2026) SICK is active, legal situation “Normale toestand”, started on 29 June 1987.

Is SICK registered on Peppol?

Yes, SICK is registered on the Peppol network with ID 0208:0431448872.

What is the enterprise number of SICK?

The enterprise number of SICK is BE0431448872.

When was SICK founded?

SICK was founded on 29 June 1987.

Who are the directors of SICK?

According to the 2025 annual accounts, the directors of SICK are: Massimo Azzerri, Alan Reeves, Jan Van Hoof.

Is SICK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 June 1987; 3 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did SICK make in 2025?

SICK posted a profit after taxes of € 607,693 in financial year 2025.

What is the revenue of SICK?

In its most recent annual accounts (2025), SICK reported revenue of € 27,622,959.

How much does an employee at SICK earn?

The average wage cost per full-time employee at SICK was € 142,000 in 2025: staff costs of € 5.3 million for 37.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does SICK have?

According to the 2025 annual accounts, SICK has 37.1 full-time equivalents (FTE).

SICK (Public Limited) - Asse - BE0431448872

Dossier SICK, printed on 29 October 2026 from databakkes.be/en/0431448872/sick. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2023.

Financials

Financial year 2025

SICK from Asse, company number BE0431448872, closed financial year 2025 with a result of € 607,693 after tax. For that financial year SICK recorded revenue of € 27.6 million and equity of € 4.1 million. Compared with financial year 2024, the result moved from € 10.2 million to € 607,693. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Healthy

€ 4.1 million

▼ 32% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 607,693

▼ 94% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 30

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 2.5 million paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

37.1

▼ 14.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 1.6 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 5.3 million

▼ 25% vs 2024

€ 142,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2.3 million

▲ € 2.3 million vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 35 days on average.

Taxes and wages

€ 4.9 million

▼ 4% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Revenue	€ 41,460,344 Revenue 2023: € 41,460,344 First fiscal year in the series	€ 37,599,470 Revenue 2024: € 37,599,470 ▼ 9% vs 2023 (€ 41,460,344) Unfavourable step	€ 27,622,959 Revenue 2025: € 27,622,959 ▼ 27% vs 2024 (€ 37,599,470) Unfavourable step	▼ 27%
Profit after taxes	€ 1,271,411 Profit after taxes 2023: € 1,271,411 First fiscal year in the series	€ 10,196,226 Profit after taxes 2024: € 10,196,226 ▲ € 8.9 million vs 2023 (€ 1,271,411) Favourable step	€ 607,693 Profit after taxes 2025: € 607,693 ▼ 94% vs 2024 (€ 10,196,226) Unfavourable step	▼ 94%
Equity	€ 5,780,366 Equity 2023: € 5,780,366 First fiscal year in the series	€ 5,976,592 Equity 2024: € 5,976,592 ▲ 3% vs 2023 (€ 5,780,366) Favourable step	€ 4,084,285 Equity 2025: € 4,084,285 ▼ 32% vs 2024 (€ 5,976,592) Unfavourable step	▼ 32%
Total debts	€ 10,984,899 Total debts 2023: € 10,984,899 First fiscal year in the series	€ 16,443,176 Total debts 2024: € 16,443,176 ▲ 50% vs 2023 (€ 10,984,899) Unfavourable step	€ 10,355,812 Total debts 2025: € 10,355,812 ▼ 37% vs 2024 (€ 16,443,176) Favourable step	▼ 37%
Cash	€ 30 Cash 2023: € 30 First fiscal year in the series	€ 30 Cash 2024: € 30 Unchanged (€ 30) Unchanged	€ 30 Cash 2025: € 30 Unchanged (€ 30) Unchanged
Retained profit	€ 5,705,998 Retained profit 2023: € 5,705,998 First fiscal year in the series	€ 5,902,224 Retained profit 2024: € 5,902,224 ▲ 3% vs 2023 (€ 5,705,998) Favourable step	€ 4,009,917 Retained profit 2025: € 4,009,917 ▼ 32% vs 2024 (€ 5,902,224) Unfavourable step	▼ 32%
Dividend	€ 1,000,000 Dividend 2023: € 1,000,000 First fiscal year in the series	€ 10,000,000 Dividend 2024: € 10,000,000 ▲ € 9 million vs 2023 (€ 1,000,000) Unchanged	€ 2,500,000 Dividend 2025: € 2,500,000 ▼ 75% vs 2024 (€ 10,000,000) Unchanged	▼ 75%
Balance sheet total	€ 16,806,515 Balance sheet total 2023: € 16,806,515 First fiscal year in the series	€ 22,944,830 Balance sheet total 2024: € 22,944,830 ▲ 37% vs 2023 (€ 16,806,515) Unchanged	€ 15,207,243 Balance sheet total 2025: € 15,207,243 ▼ 34% vs 2024 (€ 22,944,830) Unchanged	▼ 34%
Employees (FTE)	50.9 Employees (FTE) 2023: 50.9 First fiscal year in the series	51.6 Employees (FTE) 2024: 51.6 ▲ 0.7 vs 2023 (50.9) Unchanged	37.1 Employees (FTE) 2025: 37.1 ▼ 14.5 vs 2024 (51.6) Unchanged	▼ 14.5

Key figures of SICK, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SICK?

What happened at SICK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 Massimo Azzerri stepped down as director. NBB
2027 Alan Reeves stepped down as director. NBB
2027 Jan Van Hoof stepped down as director. NBB
Jul 2, 2026 New annual accounts for financial year 2025: profit of € 607,693 (▼ 94% vs 2024). Source: NBB ↗
2025 Massimo Azzerri became a director. NBB
2024 Alan Reeves became a director. NBB
2024 Jan Van Hoof became a director. NBB
Nov 3, 1988 New establishment in Asse. KBO

In short

From € 1.3 million profit in 2023 to € 607,693 profit in 2025.

Paid € 4.8 million in corporate taxes since 2023.

Best year ever: 2024, with € 10.2 million profit.

Paid out € 13.5 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

SICK AG 100%

SICK

The shares are held by SICK AG (100%).

Directors

According to the 2025 annual accounts

Massimo Azzerri

Director

since 2025 · until 2028

Alan Reeves

Director

since 2024 · until 2027

Jan Van Hoof

Director

since 2024 · until 2027

Shareholders

SICK AG

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Doornveld 10

1731 Asse

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0431.448.872

VAT number

BE 0431.448.872

Registered office

Doornveld 10, 1731 Asse

Names & denominations

SICK

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

29 June 1987

Peppol

Active · Active since 10 Jul 2026

Activities · NACE

Groothandel in meet-, controle- en navigatieinstrumenten

Groothandel in andere machines en werktuigen, neg

Groothandel in vervoermiddelen met uitzondering van auto's, motorrijwielen en rijwielen, in meetapparaten en -instrumenten, in navigatieapparatuur en andere diverse machines en uitrusting voor de nijv

Groothandel in andere machines en werktuigen, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

SICK

Warning lights

Financials

What happened to SICK?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions